Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FWBTK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,447
Award facts
- Contract value 100% obligated
- $11,446.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,446.90 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. Dupixent (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, asthma, and other allergic conditions, representing a specialized pharmaceutical product within the military healthcare supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications and medical supplies to support Department of Defense healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capability in fulfilling federal medical procurement requirements through multiple competitive awards across diverse therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FWBTK?
SPE2DB25FWBTK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FWBTK worth?
The government has obligated $11,447 on SPE2DB25FWBTK.
Is contract SPE2DB25FWBTK an order under another contract?
Yes. SPE2DB25FWBTK is a delivery order under SPE2DB25D3022, an indefinite delivery contract.
Was contract SPE2DB25FWBTK competed?
The extent of competition for SPE2DB25FWBTK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award